Universe Pharmaceuticals to effect 6-for-1 share consolidation

Universe Pharmaceuticals announced that the Company plans to effect a share consolidation of six ordinary shares with par value of $0.003125 per share each in the Company’s issued and unissued share capital into one ordinary share with par value of $0.01875. As a result of the Share Consolidation, each six pre-consolidation ordinary shares outstanding will automatically combine and convert to one issued and outstanding ordinary share without any action on the part of the shareholders. The Share Consolidation will be effective at 5:00 p.m. Cayman Islands time on July 27, 2023. Beginning with the opening of trading on July 28, 2023, U.S. Eastern time, the Company’s ordinary shares will begin trading on a post-Share Consolidation basis on the Nasdaq Global Market under the same symbol “UPC” but under a new CUSIP number of G9442G 112. No fractional shares will be issued in connection with the Share Consolidation. All fractional shares will be rounded up to the whole number of shares. Immediately following the Share Consolidation, the authorized share capital of the Company will be $3,125,000 divided into 150,000,000 ordinary shares, par value $0.01875 per share and 16,666,666.6666 preferred shares, par value $0.01875 per share.